Drug
Vigabatrin clinical trials
Also written Sabril and CPP-109.
Keep track of what changes. Save the Vigabatrin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
18 studies that test it; most in 2008 (3)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2020 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 12
Catalyst Pharmaceuticals, Inc. (3) · Lundbeck LLC (2) · University of Pennsylvania (2) · Washington University School of Medicine (1) · Martina Bebin (1) · Orphelia Pharma (1) · Barbara J. Coffey (1) · Baylor College of Medicine (1)
Often tested with
Tested in the same studies.
Sirolimus (1) · Multimodality Therapy (1) · Prednisolone (1) · Cocaine (1)
Studies
Open first, then newest update. How each study uses Vigabatrin is read from its arms, and is right about nine times in ten.
Testing it · 18
- Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in InfantsRecruitingPhase 2/3Katarzyna KotulskaNCT04987463Written as Vigabatrin
- Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile SpasmRecruitingNot applicableKullasate SakpichaisakulNCT04302116Written as Combination therapy with vigabatrin and prednisolone
- Vigabatrin and Insulin SensitivityCompletedPhase 2Washington University School of MedicineNCT04321395Written as Vigabatrin
- Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis ComplexCompletedPhase 2Martina BebinNCT02849457Written as Early Vigabatrin
- Effect of Vigabatrin in Refractory Autoimmune Encephalitis PatientsWithdrawnNot applicableSeoul National University HospitalNCT03003143Written as Vigabatrin 500 MG
- Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine DependenceTerminatedPhase 2Catalyst Pharmaceuticals, Inc.NCT00730522Written as CPP-109 vigabatrin
- Vigabatrin for Cocaine and Alcohol DependenceTerminatedPhase 2University of PennsylvaniaNCT01335867Written as Vigabatrin
- Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial EpilepsyCompletedNot applicableOrphelia PharmaNCT02220114Written as Vigabatrin: Vigabatrin new ST formulation then Sabril®
- Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's DisorderCompletedPhase 1/2Barbara J. CoffeyNCT01585207Written as vigabatrin
- Assessment of GVG for the Treatment of Methamphetamine DependenceCompletedPhase 1Baylor College of MedicineNCT00506935Written as GVG
- Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) PatientsTerminatedPhase 4University of PennsylvaniaNCT01266291Written as vigabatrin
- Vigabatrin Ph 1 Cocaine Interaction StudyCompletedPhase 1National Institute on Drug Abuse (NIDA)NCT00626834Written as Vigabatrin
- Effects of Vigabatrin on Cocaine Self-AdministrationTerminatedPhase 2New York State Psychiatric InstituteNCT00373581Written as Vigabatrin
- A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)CompletedPhase 4Lundbeck LLCNCT01278173Written as Sabril
- Vigabatrin for the Treatment of Cocaine DependencyCompletedPhase 2/3Catalyst Pharmaceuticals, Inc.NCT01281202Written as Vigabatrin
- Vigabatrin for Treatment of Cocaine DependenceCompletedPhase 2Catalyst Pharmaceuticals, Inc.NCT00611130Written as vigabatrin
- An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile SpasmsWithdrawnPhase 4Lundbeck LLCNCT01413711Written as Vigabatrin
- Double Blind Study of Vigabatrin for the Treatment of Cocaine DependenceCompletedPhase 2NYU Langone HealthNCT00527683Written as Vigabatrin
Given in every arm · 1 — Vigabatrin is usual care beside what is tested
As the comparator · 3 — what is tested is compared with Vigabatrin
- A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile SpasmsWithdrawnPhase 3AmzellNCT05128344Written as Vigabatrin, oral
- A Novel Approach to Infantile SpasmsSuspendedPhase 3University of Colorado, DenverNCT03347526Written as Vigabatrin
- Prednisolone Versus Vigabatrin in the First-line Treatment of Infantile SpasmsWithdrawnPhase 3The Hospital for Sick ChildrenNCT02299115Written as Vigabatrin
Codes
What other systems call Vigabatrin · ClinicalTrials.gg INT008775
- MeSH (NLM) D020888VigabatrinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) GR120KRT6KVIGABATRINConfirmed FDA, NLM, Wikidata
- RxNorm 14851Confirmed FDA, Wikidata
- Wikidata Q421663vigabatrinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87611VigabatrinOne source FDA
- DrugBank DB01080One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D020888 | Vigabatrin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | GR120KRT6K | VIGABATRIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 14851 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421663 | vigabatrin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87611 | Vigabatrin | One source FDA |
| DrugBank | DB01080 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.